COLUMBUS—State Rep. Randi Clites (D-Ravenna), along with a bipartisan group of co-sponsors, introduced House Concurrent Resolution (HCR) 29 calling on the Food and Drug Administration (FDA) and Congress to take action to remedy the drug shortage problem in America.


The resolution calls on the federal government to do the following:



  • Enhance methods and procedures for monitoring and assessing risks to the supply of critical drugs,

  • Establish incentives to encourage the production of drugs at risk of shortage,

  • Introduce necessary safeguards to prevent future drug shortages.


“Drug shortages put patients’ lives at risk and increase health care costs, yet most are preventable with proper notification and coordination,” said Rep. Clites. “Doctors, pharmaceutical companies and the FDA have all identified drug shortages as an issue, yet nothing has been done to remedy the problem. We are now stuck with the consequences of this inaction during a pandemic.”


There are currently 111 drugs in shortage, according to the U.S. FDA.[1] GoodRX attributes 24 of these drug shortages to the COVID-19 pandemic including hydroxychloroquine, albuterol inhalers and drugs necessary for patients on ventilators.[2]  Even prior to the COVID-19 pandemic, drug shortages have been a rising issue in the United States.


HCR 29 has been referred to the House Agriculture and Rural Development Committee and awaits hearings.


[1] https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm


2 https://www.goodrx.com/blog/covid-19-drug-shortages-updates/


-30-


 
 
 
 
  
Featured Posts

Rep. Clites, House Dems Call For A "responsible Restart" For Ohio

 

State Rep. Randi Clites (D-Ravenna) calls for a “responsible restart” for Ohio, outlining 10 recommendations following several weeks of testimony during the OHIO 2020 Economic Recovery Task Force proceedings, as well as feedback heard from constituents, local health officials and business leaders. 



 
 

Rep. Clites' Ohio Rare Disease Advisory Council Act Passes Health Committee Unanimously

 

Rep. Randi Clites (D-Ravenna) today announced the unanimous vote of the Ohio House Health Committee to favorably report House Bill 412, to create the Ohio Rare Disease Advisory Council. Rep. Clites and Rep. Tim Ginter (R-Salem) are joint sponsors of the bill.



 
 

Dem Lawmakers Urge Statehouse Leaders To Pass Bill To Protect Healthcare Coverage For Ohioans With Pre-existing Conditions

 

State Reps. Jeff Crossman (D- Parma) and Randi Clites (D-Ravenna) today called on Statehouse leaders to protect Ohioans’ healthcare by advancing the bipartisan Pre-Existing Protection Act, House Bill 390. The call comes hours after a decision in Texas v. United States raised more uncertainty about the Affordable Care Act’s (ACA) future, including its provision to protect healthcare access for those with pre-existing conditions.  



 
 

Lawmakers Introduce Bipartisan Ohio Rare Disease Council Act

 

Today, state Reps. Randi Clites (D-Ravenna) and Tim Ginter (R-Salem) held a Statehouse press conference to introduce bipartisan legislation to create the Ohio Rare Disease Advisory Council. The bill would bring together medical researchers, physicians, nurses, patients, lawmakers and state officials to begin addressing many of the issues facing those living with rare diseases.